MEA Metabolic Testing Market

Middle East & Africa Metabolic Testing Market Size (2024 to 2029)

The metabolic testing market size in the Middle East and Africa is expected to be valued at USD 30.77 million in 2024 and USD 38.90 million by 2029, growing at a CAGR of 4.8% from 2024 to 2029.

The rise in the incidence of lifestyle problems in the MEA region, as well as rising healthcare expenditures, has significantly impacted the expansion of the MEA metabolic testing market.

One of the primary factors that drive the growth of the MEA metabolic testing market is increased investments connected with the development of technological advances, as well as an increase in a sedentary lifestyle. However, other essential aspects, like rising healthcare awareness and living standards, would help moderate the market's development rate.

The factors such as current physical activity levels. As a result, the metabolic testing market is being pushed by the increased prevalence of lifestyle conditions like heart disease, obesity, and diabetes, technological advancements, and healthcare spending.

The high cost of equipment & software and the reimbursement concerns will stymie market expansion and pose a challenge to the metabolic testing market. 

However, the lack of skilled professionals & better infrastructure & facilities is the significant factor that hinders the MEA metabolic testing market.

This research report on the Middle East & Africa Metabolic Testing Market has been segmented and sub-segmented into the following categories.

Middle East & Africa Metabolic Testing Market - By Product

• CPET

• Body Composition Analysis
• ECG
• Portable System

Middle East & Africa Metabolic Testing Market - By Application

• Critical Care
• Lifestyle Diseases

Middle East & Africa Metabolic Testing Market - By Technology

• REE
• Body Composition Analysis

Middle East & Africa Metabolic Testing Market - By End User

• Gym
• Sports
• Hospital

Middle East & Africa Metabolic Testing Market - By Country

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the Middle East and Africa metabolic testing market holds a moderate share of the worldwide market due to high healthcare costs and a rising living standard during the forecast period.

The UAE Metabolic Testing Market is predicted to maintain its market share and revenue over the projection period owing to the increased demand for high-quality medical care and expanding government initiatives.

The Saudi Arabia Metabolic Testing Market is expected to develop at the fastest rate during the period because the technical improvements in the healthcare IT sector have made it possible to integrate complicated healthcare & IT systems effectively.

The South African Metabolic Testing Market is estimated to grow at a decent CAGR over the forecast period. This is because metabolism patterns and metabolic capacity have been established using metabolic tests to manage such problems in regions with high fasting glucose levels and abnormal obesity. 

KEY MARKET PLAYERS

Companies playing a major role in the MEA Metabolic Testing Market profiled in the report are Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), KORR Medical Technologies, Inc. (U.S.), CareFusion Corporation (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), and Microlife Medical Home Solutions, Inc. (U.S.).,